BROK
Bio-Age

Kiron Canon · Genius, Live Long and Prosper

Peptide Desk

Educational index. Dated 2026-10-27. 152 names.

Caution. This page is educational intelligence. It is not medical advice, not a prescription, and not an offer to sell any compound. BROK does not dose, source, or recommend peptides. Consult a licensed clinician. Athletes must read the current WADA list.

The author's own peptide experimentation is limited because of those risks. Genius, Live Long and Prosper holds that quality protein and collagen ingestion — eggs and collagen supplementation — provide the amino-acid precursor levels a healthy human needs. That is the house first path. Injectables are a specialist medical decision.

Public 152-name map and locators taken from Superpower Health's Peptide Library sitemap and index as of 2026-10-27 (https://x.com/superpower/status/2114785602592035166; https://superpower.com/guides/peptides/). Superpower terms forbid robot copy of their prose; this desk does not rehost their guides. FDA bucket, compounding, WADA, and expanded cards are Nabu classifications from FDA, DailyMed, PubMed, and WADA primary pages. Where a fact is not shown on a primary page, the field says so.

Humans stay free here. Machines: unpaid JSON /peptides.json. Dated claims 50 $POCK or $0.05 USDC at /api/x402/peptides. dest-payTo is in the shop.

71 approved · 26 trials · 34 not approved · 17 cosmetic · 4 withdrawn

FDA-approved (71)

  • Abaloparatide

    Bones & muscles

    Abaloparatide is an FDA-approved peptide drug. Sold as Tymlos. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Afamelanotide

    Skin & aging

    Afamelanotide is an FDA-approved peptide drug. Sold as Scenesse. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Angiotensin II

    Heart & blood

    Angiotensin II is an FDA-approved peptide drug. Sold as Giapreza. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Bacitracin

    Skin & aging

    Bacitracin is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Bivalirudin

    Heart & blood

    Bivalirudin is an FDA-approved peptide drug. Sold as Angiomax. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Bremelanotide

    Brain & sleep

    Bremelanotide is an FDA-approved peptide drug. Sold as Vyleesi. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

    Class. Melanocortin agonist (PT-141 as the research name)

    Human evidence. FDA-approved as Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Labelled GI and blood-pressure effects. Not a tanning peptide.

    FDA. Approved finished drug. Gray-market PT-141 vials are not that product.

    Sport. Approved therapeutic; sport-specific review.

  • Calcitonin (salmon)

    Bones & muscles

    Calcitonin (salmon) is an FDA-approved peptide drug. Sold as Miacalcin. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Cetrorelix

    Sexual & reproductive

    Cetrorelix is an FDA-approved peptide drug. Sold as Cetrotide. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Corticotropin

    Hormones & metabolism

    Corticotropin is an FDA-approved peptide drug. Sold as Acthar. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Cosyntropin

    Hormones & metabolism

    Cosyntropin is an FDA-approved peptide drug. Sold as Cortrosyn. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Cyclosporine

    Immune & defense

    Cyclosporine is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Dalbavancin / oritavancin / telavancin

    Skin & aging

    Dalbavancin / oritavancin / telavancin is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Daptomycin

    Skin & aging

    Daptomycin is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Dasiglucagon

    Digestive & weight

    Dasiglucagon is an FDA-approved peptide drug. Sold as Zegalogue. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Degarelix

    Sexual & reproductive

    Degarelix is an FDA-approved peptide drug. Sold as Firmagon. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Desmopressin

    Heart & blood

    Desmopressin is an FDA-approved peptide drug. Sold as DDAVP. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Difelikefalin

    Skin & aging

    Difelikefalin is an FDA-approved peptide drug. Sold as Korsuva. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Dulaglutide

    Hormones & metabolism

    Dulaglutide is an FDA-approved peptide drug. Sold as Trulicity. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Ecallantide

    Skin & aging

    Ecallantide is an FDA-approved peptide drug. Sold as Kalbitor. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Echinocandins

    Heart & blood

    Echinocandins is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Enfuvirtide

    Immune & defense

    Enfuvirtide is an FDA-approved peptide drug. Sold as Fuzeon. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Eptifibatide

    Heart & blood

    Eptifibatide is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Etelcalcetide

    Bones & muscles

    Etelcalcetide is an FDA-approved peptide drug. Sold as Parsabiv. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Exenatide

    Hormones & metabolism

    Exenatide is an FDA-approved peptide drug. Sold as Byetta / Bydureon. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Ga-68 dotatate

    Digestive & weight

    Ga-68 dotatate is an FDA-approved peptide drug. Sold as Netspot. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Ganirelix

    Sexual & reproductive

    Ganirelix is an FDA-approved peptide drug. Sold as Ganirelix. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Glucagon

    Digestive & weight

    Glucagon is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Goserelin

    Sexual & reproductive

    Goserelin is an FDA-approved peptide drug. Sold as Zoladex. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Histrelin

    Sexual & reproductive

    Histrelin is an FDA-approved peptide drug. Sold as Vantas / Supprelin. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Human chorionic gonadotropin

    Sexual & reproductive

    Human chorionic gonadotropin is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Icatibant

    Skin & aging

    Icatibant is an FDA-approved peptide drug. Sold as Firazyr. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Insulin analogs

    Hormones & metabolism

    Insulin analogs is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Lanreotide

    Digestive & weight

    Lanreotide is an FDA-approved peptide drug. Sold as Somatuline. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Leuprolide

    Sexual & reproductive

    Leuprolide is an FDA-approved peptide drug. Sold as Lupron. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Linaclotide

    Digestive & weight

    Linaclotide is an FDA-approved peptide drug. Sold as Linzess. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Liraglutide

    Digestive & weight

    Liraglutide is an FDA-approved peptide drug. Sold as Victoza / Saxenda. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Lixisenatide

    Hormones & metabolism

    Lixisenatide is an FDA-approved peptide drug. Sold as Adlyxin. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Lutetium Lu-177 dotatate

    Digestive & weight

    Lutetium Lu-177 dotatate is an FDA-approved peptide drug. Sold as Lutathera. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Lutetium Lu-177 vipivotide tetraxetan

    Sexual & reproductive

    Lutetium Lu-177 vipivotide tetraxetan is an FDA-approved peptide drug. Sold as Pluvicto. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Mecasermin

    Hormones & metabolism

    Mecasermin is an FDA-approved peptide drug. Sold as Increlex. Desk is educational; a clinician decides use.

    WADA S2 · compounding n/a finished drug · public locator

  • Motixafortide

    Heart & blood

    Motixafortide is an FDA-approved peptide drug. Sold as Aphexda. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Nafarelin

    Sexual & reproductive

    Nafarelin is an FDA-approved peptide drug. Sold as Synarel. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Octreotide

    Digestive & weight

    Octreotide is an FDA-approved peptide drug. Sold as Sandostatin. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Oxytocin

    Sexual & reproductive

    Oxytocin is an FDA-approved peptide drug. Sold as Pitocin. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Palopegteriparatide

    Bones & muscles

    Palopegteriparatide is an FDA-approved peptide drug. Sold as Yorvipath. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Parathyroid hormone

    Bones & muscles

    Parathyroid hormone is an FDA-approved peptide drug. Sold as Natpara. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Pasireotide

    Hormones & metabolism

    Pasireotide is an FDA-approved peptide drug. Sold as Signifor. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Pegcetacoplan

    Heart & blood

    Pegcetacoplan is an FDA-approved peptide drug. Sold as Empaveli / Syfovre. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Pegvisomant

    Hormones & metabolism

    Pegvisomant is an FDA-approved peptide drug. Sold as Somavert. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Plecanatide

    Digestive & weight

    Plecanatide is an FDA-approved peptide drug. Sold as Trulance. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Polymyxin B / colistin

    Immune & defense

    Polymyxin B / colistin is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Pramlintide

    Hormones & metabolism

    Pramlintide is an FDA-approved peptide drug. Sold as Symlin. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • PT-141

    Brain & sleep

    PT-141 is an FDA-approved peptide drug. Sold as research name of bremelanotide (Vyleesi). Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Secretin

    Hormones & metabolism

    Secretin is an FDA-approved peptide drug. Sold as ChiRhoStim. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Semaglutide

    Digestive & weight

    Semaglutide is an FDA-approved peptide drug. Sold as Ozempic / Wegovy / Rybelsus. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

    Class. GLP-1 receptor agonist

    Human evidence. STEP 1 (NEJM): ~14.9% mean weight loss vs 2.4% placebo at 68 weeks. SELECT (NEJM): 20% reduction in major cardiovascular events (HR 0.80) in 17,604 adults with overweight/obesity and established CVD without diabetes.

    FDA. FDA-approved as Ozempic, Wegovy, and Rybelsus for labelled uses including type 2 diabetes, chronic weight management, cardiovascular risk reduction, CKD in T2D, and noncirrhotic MASH (Wegovy). Boxed warning for thyroid C-cell tumors in rodents.

    Sport. Approved therapeutic; athletes still need sport-specific review.

  • Setmelanotide

    Digestive & weight

    Setmelanotide is an FDA-approved peptide drug. Sold as Imcivree. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Sincalide

    Digestive & weight

    Sincalide is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Somapacitan

    Hormones & metabolism

    Somapacitan is an FDA-approved peptide drug. Sold as Sogroya. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Somatropin (rhGH)

    Hormones & metabolism

    Somatropin (rhGH) is an FDA-approved peptide drug. Sold as Genotropin and others. Desk is educational; a clinician decides use.

    WADA S2 · compounding n/a finished drug · public locator

  • Teduglutide

    Digestive & weight

    Teduglutide is an FDA-approved peptide drug. Sold as Gattex. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Teriparatide

    Bones & muscles

    Teriparatide is an FDA-approved peptide drug. Sold as Forteo. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Terlipressin

    Digestive & weight

    Terlipressin is an FDA-approved peptide drug. Sold as Terlivaz. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Tesamorelin

    Digestive & weight

    Tesamorelin is an FDA-approved peptide drug. Sold as Egrifta. Desk is educational; a clinician decides use.

    WADA S2 · compounding n/a finished drug · public locator

    Class. GHRH analogue

    Human evidence. Approved as Egrifta for reduction of excess abdominal fat in HIV-associated lipodystrophy. Off-label and compounded versions are a different legal object.

    FDA. FDA-approved branded product. Compounded/off-label tesamorelin is a separate row on this desk.

    Sport. S2 peptide hormone analogue in sport.

  • Tirzepatide

    Digestive & weight

    Tirzepatide is an FDA-approved peptide drug. Sold as Mounjaro / Zepbound. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

    Class. GIP/GLP-1 receptor agonist

    Human evidence. SURMOUNT-1 reported ~20.9% mean weight loss at 15 mg over 72 weeks in a separate trial from STEP 1. Dual-incretin, not interchangeable with semaglutide.

    FDA. FDA-approved as Mounjaro (T2D) and Zepbound (weight). Labelled drug; clinician-prescribed.

    Sport. Approved therapeutic; sport-specific review.

  • Triptorelin

    Sexual & reproductive

    Triptorelin is an FDA-approved peptide drug. Sold as Trelstar. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Trofinetide

    Brain & sleep

    Trofinetide is an FDA-approved peptide drug. Sold as Daybue. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Vancomycin

    Heart & blood

    Vancomycin is an FDA-approved peptide drug. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Vasopressin

    Heart & blood

    Vasopressin is an FDA-approved peptide drug. Sold as Vasostrict. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Vosoritide

    Bones & muscles

    Vosoritide is an FDA-approved peptide drug. Sold as Voxzogo. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Ziconotide

    Brain & sleep

    Ziconotide is an FDA-approved peptide drug. Sold as Prialt. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

  • Zilucoplan

    Bones & muscles

    Zilucoplan is an FDA-approved peptide drug. Sold as Zilbrysq. Desk is educational; a clinician decides use.

    WADA therapeutic_check_list · compounding n/a finished drug · public locator

US product withdrawn / discontinued (4)

  • Albiglutide

    Hormones & metabolism

    Albiglutide was FDA-approved and later left the US market. Sold as Tanzeum (withdrawn).

    WADA unknown_verify · compounding n/a finished drug · public locator

  • Desirudin

    Heart & blood

    Desirudin was FDA-approved and later left the US market. Sold as Iprivask (discontinued).

    WADA unknown_verify · compounding n/a finished drug · public locator

  • Nesiritide

    Heart & blood

    Nesiritide was FDA-approved and later left the US market. Sold as Natrecor (discontinued).

    WADA unknown_verify · compounding n/a finished drug · public locator

  • Sermorelin

    Bones & muscles

    Sermorelin was FDA-approved and later left the US market. Sold as Geref (discontinued).

    WADA S2 · compounding n/a finished drug · public locator

    Class. GHRH 1-29 analogue

    Human evidence. Geref was FDA-approved then discontinued. Compounded sermorelin is not the discontinued branded product.

    FDA. Finished US product discontinued. Compounded copies are a separate legal question.

    Sport. S2.

In clinical trials (26)

  • Amycretin

    Digestive & weight

    Amycretin is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Apraglutide

    Digestive & weight

    Apraglutide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Aviptadil

    Immune & defense

    Aviptadil is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Balixafortide

    Heart & blood

    Balixafortide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Brilacidin

    Digestive & weight

    Brilacidin is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Cagrilintide

    Digestive & weight

    Cagrilintide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • CagriSema

    Digestive & weight

    CagriSema is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Davunetide

    Brain & sleep

    Davunetide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Efpeglenatide

    Hormones & metabolism

    Efpeglenatide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Elamipretide

    Hormones & metabolism

    Elamipretide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Enlicitide

    Digestive & weight

    Enlicitide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Glepaglutide

    Digestive & weight

    Glepaglutide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Larazotide acetate

    Digestive & weight

    Larazotide acetate is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • LTX-315

    Skin & aging

    LTX-315 is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Mazdutide

    Digestive & weight

    Mazdutide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Murepavadin

    Immune & defense

    Murepavadin is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Nangibotide

    Immune & defense

    Nangibotide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • NNZ-2591

    Brain & sleep

    NNZ-2591 is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Pemvidutide

    Digestive & weight

    Pemvidutide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Petrelintide

    Digestive & weight

    Petrelintide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • PN-943

    Digestive & weight

    PN-943 is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Retatrutide

    Digestive & weight

    Retatrutide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Rusfertide

    Heart & blood

    Rusfertide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Selepressin

    Heart & blood

    Selepressin is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Survodutide

    Digestive & weight

    Survodutide is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Trofinetide predecessor programs

    Brain & sleep

    Trofinetide predecessor programs is in clinical development. Not an approved US drug as of 2026-10-27.

    WADA unknown_verify · compounding closed or unlisted · public locator

Not FDA-approved (34)

  • 5-Amino-1MQ

    Digestive & weightsmall molecule

    5-Amino-1MQ is a small molecule often sold next to peptides. FDA compounding risk listed. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • AOD-9604

    Digestive & weight

    AOD-9604 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding nominated withdrawn · public locator

    Class. HGH fragment analogue

    Human evidence. FDA withdrawn-nomination page: immunogenicity / impurity; limited safety information; serious adverse events mentioned with causality unclear.

    FDA. Not approved.

    Sport. S0 typical.

  • BPC-157

    Digestive & weight

    BPC-157 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding nominated withdrawn · public locator

    Class. Synthetic pentadecapeptide (gastric-derived fragment)

    Human evidence. HSS Journal 2025 systematic review: 36 studies included, 35 preclinical, 1 retrospective human series n=12 with no control and no safety table (PMID 40756949).

    FDA. Never FDA-approved. Nominated for 503A compounding then withdrawn April 2026. Still not on the 503A bulks list or Category 1. PCAC July 2026 vote is advisory. Licensed US compounding remains closed as of this desk date.

    Sport. WADA S0 Non-Approved Substances. Prohibited at all times in sport.

  • Cerebrolysin

    Brain & sleep

    Cerebrolysin is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • CJC-1295

    Bones & muscles

    CJC-1295 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding nominated withdrawn · public locator

    Class. GHRH analogue (with or without DAC)

    Human evidence. FDA lists CJC-1295 under nominated-but-withdrawn compounding substances with heart-rate and vasodilatory adverse-event language. Available clinical data are limited.

    FDA. Nominated then withdrawn from Category 2. Still not a cleared 503A bulk.

    Sport. S2.

  • Gonadorelin (compounded)

    Sexual & reproductive

    Gonadorelin (compounded) is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Tesamorelin (off-label / compounded)

    Hormones & metabolism

    Tesamorelin (off-label / compounded) is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

  • Dihexa

    Brain & sleep

    Dihexa is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • DSIP (emideltide)

    Brain & sleep

    DSIP (emideltide) is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding nominated withdrawn · public locator

  • Epitalon

    Brain & sleep

    Epitalon is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding nominated withdrawn · public locator

    Class. Synthetic tetrapeptide (Ala-Glu-Asp-Gly)

    Human evidence. FDA: nominated-but-withdrawn; immunogenicity / aggregation language; no adequate human safety package on the compounding page.

    FDA. Not approved. Compounding closed.

    Sport. S0 typical for non-approved substances.

  • Follistatin-344

    Bones & muscles

    Follistatin-344 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

  • HGH fragment 176-191

    Digestive & weight

    HGH fragment 176-191 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • GHK-Cu

    Skin & aging

    GHK-Cu is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding nominated withdrawn · public locator

    Class. Copper tripeptide

    Human evidence. Topical cosmetic use is common. FDA lists injectable GHK-Cu under nominated-but-withdrawn compounding with immunogenicity language and limited human data.

    FDA. Injectable compounding closed. Topical cosmetic is a different object.

    Sport. Typical none for topical cosmetic; verify if injected.

  • GHRP-2

    Bones & muscles

    GHRP-2 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding category 2 · public locator

    Class. Growth-hormone releasing peptide

    Human evidence. FDA Category 2 (503B) for injectable and nasal routes: immunogenicity, unnatural amino acid, reports of serious events with causality not established.

    FDA. Category 2. Not approved.

    Sport. S2.

  • GHRP-6

    Bones & muscles

    GHRP-6 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding category 2 · public locator

    Class. Growth-hormone releasing peptide

    Human evidence. FDA Category 2 (503B): immunogenicity / impurity language; cortisol and glucose effects in available data.

    FDA. Category 2. Not approved.

    Sport. S2.

  • Hexarelin

    Bones & muscles

    Hexarelin is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

  • Humanin

    Hormones & metabolism

    Humanin is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • IGF-1 DES

    Bones & muscles

    IGF-1 DES is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

  • IGF-1 LR3

    Bones & muscles

    IGF-1 LR3 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

  • Ipamorelin

    Bones & muscles

    Ipamorelin is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding category 2 · public locator

    Class. Ghrelin-mimetic GHRP

    Human evidence. No FDA-approved finished drug. FDA Category 2 under 503B for ipamorelin acetate (immunogenicity / impurity / IV motility study deaths in literature; causality not always established).

    FDA. Category 2 on FDA compounding safety page as of this desk date. Not a 503A bulk.

    Sport. S2 peptide hormones and growth-factor mimetics.

  • Kisspeptin-10

    Sexual & reproductive

    Kisspeptin-10 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding category 2 · public locator

    Class. Kisspeptin fragment

    Human evidence. FDA Category 2 (503A): immunogenicity / impurity; limited safety information for proposed routes.

    FDA. Category 2. Not approved as a finished US drug.

    Sport. Verify current WADA list.

  • KPV

    Digestive & weight

    KPV is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding nominated withdrawn · public locator

  • LL-37 (cathelicidin)

    Immune & defense

    LL-37 (cathelicidin) is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding nominated withdrawn · public locator

    Class. Human cathelicidin antimicrobial peptide

    Human evidence. FDA withdrawn-nomination page: limited human safety; nonclinical notes include male-reproduction and protumorigenic signals in some tissues.

    FDA. Not approved. Nominated then withdrawn.

    Sport. Verify list.

  • Mechano growth factor

    Bones & muscles

    Mechano growth factor is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding nominated withdrawn · public locator

  • Melanotan I

    Skin & aging

    Melanotan I is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Melanotan II

    Skin & aging

    Melanotan II is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding nominated withdrawn · public locator

    Class. Melanocortin agonist

    Human evidence. Not FDA-approved. FDA compounding page lists immunogenicity / impurity language. Case reports of priapism and pigment change circulate in the literature.

    FDA. Nominated-but-withdrawn compounding substance. Unapproved.

    Sport. Verify current WADA list; often treated as prohibited.

  • MK-677 (ibutamoren)

    Bones & musclessmall molecule

    MK-677 (ibutamoren) is a small molecule often sold next to peptides. FDA compounding risk listed. Educational desk only.

    WADA S4 · compounding category 2 · public locator

    Class. Non-peptide ghrelin-receptor agonist (small molecule)

    Human evidence. FDA Category 2: a hip-fracture recovery RCT was terminated early for a congestive-heart-failure safety signal.

    FDA. Category 2 for 503A and 503B. Not an approved drug. Not a peptide.

    Sport. S4 hormone and metabolic modulators (ibutamoren).

  • MOTS-c

    Hormones & metabolism

    MOTS-c is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

    Class. Mitochondrial-derived peptide

    Human evidence. No FDA-approved product. Human evidence remains early.

    FDA. Not approved. Superpower states it does not facilitate research-only MOTS-c.

    Sport. Treat as non-approved / verify list.

  • Selank

    Brain & sleep

    Selank is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • Semax

    Brain & sleep

    Semax is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

  • TB-500

    Bones & muscles

    TB-500 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

    Class. Synthetic fragment of thymosin beta-4

    Human evidence. No completed controlled human efficacy trials as an FDA-approved drug. Often discussed with BPC-157 in recovery forums; different sequence and mechanism.

    FDA. Not FDA-approved.

    Sport. S2 (thymosin beta-4 / related fragments).

  • Thymosin alpha-1

    Immune & defense

    Thymosin alpha-1 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA unknown_verify · compounding closed or unlisted · public locator

  • Thymosin beta-4

    Bones & muscles

    Thymosin beta-4 is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S2 · compounding closed or unlisted · public locator

  • Thymulin

    Immune & defense

    Thymulin is not FDA-approved for any human use. Human evidence is thin or absent. Educational desk only.

    WADA S0 · compounding closed or unlisted · public locator

Cosmetic / topical (17)

  • Acetyl hexapeptide-8

    Skin & aging

    Acetyl hexapeptide-8 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Acetyl octapeptide-3

    Skin & aging

    Acetyl octapeptide-3 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Acetyl tetrapeptide-5

    Skin & aging

    Acetyl tetrapeptide-5 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Carnosine

    Skin & aging

    Carnosine is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Copper tripeptide-1

    Skin & aging

    Copper tripeptide-1 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Dipeptide diaminobutyroyl benzylamide diacetate

    Skin & aging

    Dipeptide diaminobutyroyl benzylamide diacetate is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Glutathione

    Skin & aging

    Glutathione is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Hexapeptide-9

    Skin & aging

    Hexapeptide-9 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Nonapeptide-1

    Skin & aging

    Nonapeptide-1 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Oligopeptide-1

    Skin & aging

    Oligopeptide-1 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Palmitoyl hexapeptide-12

    Skin & aging

    Palmitoyl hexapeptide-12 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Palmitoyl pentapeptide-4

    Skin & aging

    Palmitoyl pentapeptide-4 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Palmitoyl tetrapeptide-7

    Skin & aging

    Palmitoyl tetrapeptide-7 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Palmitoyl tripeptide-1

    Skin & aging

    Palmitoyl tripeptide-1 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Palmitoyl tripeptide-38

    Skin & aging

    Palmitoyl tripeptide-38 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Pentapeptide-18

    Skin & aging

    Pentapeptide-18 is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

  • Tripeptide-10 citrulline

    Skin & aging

    Tripeptide-10 citrulline is used in topical cosmetic formulas. Not an FDA-approved injectable drug.

    WADA none_typical · compounding n/a cosmetic · public locator

Desk date 2026-10-27. Re-open FDA before any compounding sentence. Not financial, legal, or medical advice.